Product Types

Get In Touch

From strategy development to clinical and regulatory preparations and execution–including full-lifecycle regulatory, quality and safety support–our product development program solutions apply to a wide range of biopharmaceutical areas.


Our deep scientific, regulatory and commercial experience covers the full range of cutting-edge biopharmaceutical products–from protein biopharmaceuticals and vaccines, to gene and cell therapies, to regenerative medicine products and oncolytic viruses. Whatever your area of focus, we’ll help you optimize the market opportunity.


We’re across all up-and-coming product types


Our quality, non-clinical, clinical and regulatory solutions can be applied in a customized, targeted way across the following product types:

  • Protein biopharmaceuticals, including antibodies, antibody-drug conjugates, biosimilars, enzyme replacement therapies, insulins, natural product proteins, etc;
  • Vaccines, including vectored and mRNA-based vaccines and other biotechnological approaches;
  • Gene therapies, including viral and non-viral vectors, genetically-modified cells, in vivo and ex vivo genome editing;
  • Cell therapies, including autologous and allogeneic, stem cell-based or stem cell-derived products, cellular immunotherapies;
  • Regenerative medicine products for tissue repair; and
  • Oncolytic viruses, designed to target, infect and kill cancer cells


Get In Touch

Insights Hub

Sharing insights, questioning norms, asking the right questions - we'll never lose sight of what you're striving for. Our insight and expertise will help you bring the most innovative therapies within reach of patients around the world.
Placeholder Image

Cell & Gene Therapy: Maximizing Commercialization Potential

How to Navigate the Less Obvious Barriers to Brining Advanced & Highly Targeted Treatments to

Start a conversation today

If you’re developing something truly ground-breaking, Biopharma Excellence is the nearest resource you’ll find to someone who’s been there before.


    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more